Open AccessOutcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
Author(s) -
Anivita Aggarwal,
Parul Kodan,
Nitin Gupta,
Sudeshna Ghosh,
Binit Kumar Singh,
Pankaj Jorwal,
Neeraj Nischal,
Manish Soneja,
Naveet Wig
Publication year - 2020
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_756_20
Subject(s) - medicine , capreomycin , tuberculosis , moxifloxacin , clofazimine , isoniazid , rifampicin , pyrazinamide , regimen , extensively drug resistant tuberculosis , ethambutol , mycobacterium tuberculosis , drug resistance , rifabutin , ethionamide , pharmacotherapy , antibiotics , immunology , clarithromycin , pathology , leprosy , helicobacter pylori , microbiology and biotechnology , biology